GloPID-R is the only alliance of its kind to bring together research funding organizations on a global scale to facilitate an effective and rapid research of a significant outbreak of a new or re-emerging infectious disease with epidemic and pandemic potential.

The need for the rapid development of essential diagnostics, vaccines and therapeutics at the outset of an emerging infectious disease outbreak was highlighted when Ebola struck in West Africa in 2014 and has been confirmed in the battle against COVID-19. This pandemic has underlined the importance of planning and investing in research and innovation before a health crisis occurs.

Specific objectives of GloPID-R